Literature DB >> 18777478

Adverse effects of antiepileptic drugs.

Rafael Toledano1, Antonio Gil-Nagel.   

Abstract

Adverse effects of antiepileptic drugs (AEDs) are considered by patients to be at least as important as repetitive seizures in terms of quality of life. AED toxicity is frequent and contributes to a high proportion of treatment failures. Despite its high prevalence and clinical relevance, screening for adverse reactions to AEDs is not systematically included in everyday clinical practice; therefore it is very likely that it remains underestimated. Because there is little difference among AEDs in terms of efficacy, drug selection is often based on the adverse effects profile. AED toxicity is classified according to different parameters, such as severity, time of occurrence, organ system involvement, and mechanisms of action. Although most toxic reactions to drugs can be predicted from cumulative experience, prevention is not always possible, since multiple mechanisms and individual susceptibility to each drug participate in the final outcome. However, adverse effects can be reduced and appropriate action can be taken in time by means of a high degree of suspicion, knowledge of risk factors, and close follow-up. This article highlights factors to consider for detecting and managing AED adverse effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777478     DOI: 10.1055/s-2008-1079336

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  9 in total

1.  The pharmacology of new antiepileptic drugs: does a novel mechanism of action really matter?

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2011-11-01       Impact factor: 5.749

2.  Clinical strategies for managing the overweight neurology patient.

Authors:  Lawrence J Cheskin; Carmine M Sonzone; Lisa M Davis
Journal:  Neurol Clin Pract       Date:  2012-03

Review 3.  [Drug-induced bone marrow changes].

Authors:  Hans H Kreipe
Journal:  Pathologie (Heidelb)       Date:  2022-06-09

Review 4.  In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.

Authors:  Abdelbaset A Elzagallaai; Sandra R Knowles; Michael J Rieder; John R Bend; Neil H Shear; Gideon Koren
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

5.  Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: an update.

Authors:  Paul Boon; Sebastiaan Engelborghs; Henri Hauman; An Jansen; Lieven Lagae; Benjamin Legros; Michel Ossemann; Bernard Sadzot; Katrien Smets; Etienne Urbain; Kenou van Rijckevorsel
Journal:  Acta Neurol Belg       Date:  2012-04-28       Impact factor: 2.396

6.  Systematic Adverse Drug Reaction Monitoring of Patients Under Newer Antiepileptic Drugs Using Routine Clinical Data of Inpatients.

Authors:  Annika Hilgers; Marion Schaefer
Journal:  Drugs Real World Outcomes       Date:  2016-05-25

7.  Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: First case report in Asian population.

Authors:  X T Wu; P W Hong; D J Suolang; D Zhou; H Stefan
Journal:  Epilepsy Behav Case Rep       Date:  2017-06-20

8.  Differential ketogenic diet-induced shift in CSF lipid/carbohydrate metabolome of pediatric epilepsy patients with optimal vs. no anticonvulsant response: a pilot study.

Authors:  Susan A Masino; David N Ruskin; Natalie R Freedgood; Marie Lindefeldt; Maria Dahlin
Journal:  Nutr Metab (Lond)       Date:  2021-03-01       Impact factor: 4.169

9.  Impact of Physical Activity and Medication Adherence on the Seizure Frequency and Quality of Life of Epileptic Patients: A Population Study in West Texas.

Authors:  YoonJung Lee; Yeseul Ahn; Luca Cucullo
Journal:  Biomed Res Int       Date:  2022-01-18       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.